Sensus Healthcare (SRTS) EPS (Weighted Average and Diluted) (2017 - 2025)
Sensus Healthcare has reported EPS (Weighted Average and Diluted) over the past 9 years, most recently at -$0.19 for Q4 2025.
- Quarterly results put EPS (Weighted Average and Diluted) at -$0.19 for Q4 2025, down 290.0% from a year ago — trailing twelve months through Dec 2025 was -$0.47 (down 214.63% YoY), and the annual figure for FY2025 was -$0.47, down 214.63%.
- EPS (Weighted Average and Diluted) for Q4 2025 was -$0.19 at Sensus Healthcare, down from -$0.06 in the prior quarter.
- Over the last five years, EPS (Weighted Average and Diluted) for SRTS hit a ceiling of $0.97 in Q1 2022 and a floor of -$0.19 in Q4 2025.
- Median EPS (Weighted Average and Diluted) over the past 5 years was $0.04 (2021), compared with a mean of $0.08.
- Biggest five-year swings in EPS (Weighted Average and Diluted): surged 1485.71% in 2022 and later plummeted 290.0% in 2025.
- Sensus Healthcare's EPS (Weighted Average and Diluted) stood at $0.32 in 2021, then plummeted by 43.75% to $0.18 in 2022, then skyrocketed by 44.44% to $0.26 in 2023, then crashed by 61.54% to $0.1 in 2024, then plummeted by 290.0% to -$0.19 in 2025.
- The last three reported values for EPS (Weighted Average and Diluted) were -$0.19 (Q4 2025), -$0.06 (Q3 2025), and -$0.06 (Q2 2025) per Business Quant data.